FDA Inspection 1195416 - Atara Biotherapeutics, Inc. - January 13, 2023
FDA Inspection 1195416 for Atara Biotherapeutics, Inc. on January 13, 2023. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1195416 for Atara Biotherapeutics, Inc. on January 13, 2023. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Atara Biotherapeutics, Inc.Inspection Date
January 13, 2023
Product Type
Biologics
ID: 405d6989-60e7-4ef6-af0a-ca7d42c0de2b
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox